Cargando…
Redox/pH-Responsive 2-in-1 Chimeric Nanoparticles for the Co-Delivery of Doxorubicin and siRNA
The co-delivery of chemotherapy drugs and gene-suppressing small interfering RNA (siRNA) show promise for cancer therapy. The key to the clinical realization of this treatment model will be the development of a carrier system enabling the simultaneous delivery (“co-delivery” instead of combinatorial...
Autores principales: | Wu, Hsi-Chin, Kuo, Wei-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703840/ https://www.ncbi.nlm.nih.gov/pubmed/34960912 http://dx.doi.org/10.3390/polym13244362 |
Ejemplares similares
-
pH-responsive hybrid nanoparticle with enhanced dissociation characteristic for siRNA delivery
por: Shi, Menghao, et al.
Publicado: (2018) -
pH-sensitive CAP/SiO(2) composite for efficient co-delivery of doxorubicin and siRNA to overcome multiple drug resistance
por: Cai, Zheng, et al.
Publicado: (2020) -
Dual pH-Responsive and Tumor-Targeted Nanoparticle-Mediated Anti-Angiogenesis siRNA Delivery for Tumor Treatment
por: Zhang, Xiangyang, et al.
Publicado: (2022) -
pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery
por: Yao, Yao, et al.
Publicado: (2015) -
Targeted Delivery of siRNA with pH-Responsive Hybrid Gold Nanostars for Cancer Treatment
por: Zhu, Hongyan, et al.
Publicado: (2017)